Neurodegenerative diseases: pathogenic mechanisms
Group leader
Manuel Guzmán Pastor
Tlf. 0034 91 394 46 68
Principal Investigator
- Ismael Galve Roperh
- Javier Palazuelos Diego
Collaborating Staff
- Cristina Blázquez Ortiz
- Eva Resel Mariné
- Carlos Costas Insúa
- Tania Aguado Sánchez
- Samuel Simón Sánchez
- Alicia Álvaro Blázquez
- Tánia Gavaldá Vives
- Alba Hermoso López
- Sara Ezquerro Herce
Principal Investigator
- Ismael Galve Roperh
- Javier Palazuelos Diego
Collaborating Staff
- Cristina Blázquez Ortiz
- Eva Resel Mariné
- Carlos Costas Insúa
- Tania Aguado Sánchez
- Samuel Simón Sánchez
- Alicia Álvaro Blázquez
- Tánia Gavaldá Vives
- Alba Hermoso López
- Sara Ezquerro Herce
STRATEGIC OBJECTIVES
The overall objective of our research is the study of the molecular mechanisms whereby the cannabinoid receptors act in the brain, as well as the validity of these receptors as therapeutic targets in neurodegeneration, neurorepair and neuro-oncology. Our work enables the characterisation of new mechanisms of action and cannabinoid receptor-mediated effects, and the identification of new physiopathological implications derived therein.
RESEARCH LINES
- Neurogenesis and neurorepair by cannabinoid receptors.
- Neuroprotection by cannabinoid receptors.
Location
Madrid Complutense University
Faculty of Biological Sciences
Annex Building
Department of Molecular Biochemistry and Biology
Calle José Antonio Novais, 12
28040 Madrid
0034 91 394 4668
Keywords
neurodegeneration, neurogenesis, neurorepair, neuropharmacology, cannabinoid